Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POISE-3 Trial
NCT03505723Phase 3Completed
- Sponsor
- Population Health Research Institute
- Start
- Jun 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 23
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in perioperative bleeding (4 arms), sponsored by Population Health Research Institute. Primary endpoints: Composite of life-threatening bleeding, major bleeding, and critical organ bleeding at 30 days, Composite of MINS, non-hemorrhagic stroke, peripheral arterial thrombosis, and symptomatic proximal venous thromboembolism at 30 days and 1 more. Started Jun 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
perioperative bleeding
Beyond the preview
Go deeper on NCT03505723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03505723.